DanPET AB
Developing PET ligands, biomarkers, and medicines for unmet needs.
Oversigt
- 1
- Medarbejdere
- 317t SEK
- Omsætning
- 2012
- Grundlagt
Nøglebeslutningstagere
Dan Peters
Chief Executive Officer
Beskrivelse
DanPET AB is a translational biotechnology company focused on innovation in healthcare. Its core mission is to develop novel biomarkers and future medicines addressing significant unmet medical needs. This development work is consistently performed in close collaboration with world-leading partners...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556880438801
Beslutningstagere
1 kontakter i FunnelfeedrDan Peters
Chief Executive Officer
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
GENOVIS AKTIEBOLAG
20–49 medarbejdereProvides specialized enzymes and tools for biopharma research.
ZEALAND PHARMA A/S
0 medarbejdereDeveloping peptide medicines for metabolic health challenges globally.
Newbury Pharmaceuticals AB
5–9 medarbejdereRapidly growing Nordic hybrid pharma commercializing licensed medicines for patients.
Novandi Chemistry AB
9 medarbejdereExpert provider of custom radiolabeling and labeled tool compounds.
Haga Bioscience AB
5 medarbejdereVoxlBio empowers discoveries via advanced genetic spatial analysis technology.
Udforsk mere
Spørgsmål om DanPET AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo